PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
Go Deep

Amgen Inc.

Amgen Inc. Score & Ratio Trend

DateScoreP/EP/BD/EPrice
Oct 2026 4,803 25.1 18.64 4.90 38,767.16
Oct 2026 4,803 25.0 18.64 4.90 38,763.18
Oct 2026 4,803 25.0 18.64 4.90 38,763.18
Oct 2026 4,805 25.0 18.64 4.90 38,757.41
Oct 2026 5,068 25.0 18.62 4.90 38,817.91
Oct 2026 5,068 25.0 18.62 4.90 38,817.91
Oct 2026 4,708 25.7 19.11 4.90 39,877.01
Oct 2026 4,902 25.3 18.85 4.90 39,332.55
Oct 2026 4,396 25.8 19.19 4.90 40,141.33
Oct 2026 4,301 25.9 19.32 4.90 39,978.37
Oct 2026 6,915 25.6 19.10 4.90 39,316.28
Oct 2026 6,459 26.5 19.71 4.90 40,458.08
Oct 2026 6,188 26.1 20.08 4.90 41,215.94
Oct 2026 6,240 26.9 20.00 4.90 40,963.27
Oct 2026 6,499 26.4 19.66 4.90 40,291.28
Oct 2026 6,018 27.3 20.30 4.90 41,618.70
Oct 2026 6,039 27.2 20.28 4.90 41,459.15
Oct 2026 5,775 27.8 20.69 4.90 42,219.13

Amgen Inc. Quarterly Results

Line Item Jun 2026Mar 2026Dec 2025Sep 2025
Revenue 10,054,000,000.0 8,618,000,000.0 9,866,000,000.0 9,557,000,000.0
Net Profit 2,375,000,000.0 1,819,000,000.0 1,333,000,000.0 3,216,000,000.0
EPS 4.4 3.4 2.5 6.0

Amgen Inc. Revenue & Profit: Last 5 Years

Line Item Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Revenue 36,751,000,000.0 33,424,000,000.0 28,190,000,000.0 26,323,000,000.0 —
Net Profit 7,711,000,000.0 4,090,000,000.0 6,717,000,000.0 6,552,000,000.0 —
EPS 14.3 7.6 12.6 12.2 —

Amgen Inc. Balance Sheet

Line Item Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Total Assets 90,586,000,000.0 91,839,000,000.0 97,154,000,000.0 65,121,000,000.0 —
Total Liabilities 81,928,000,000.0 85,962,000,000.0 90,922,000,000.0 61,460,000,000.0 —
Total Equity 8,658,000,000.0 5,877,000,000.0 6,232,000,000.0 3,661,000,000.0 —

Owes vs Owns

Amgen Inc. owed $0.88 for every $1 it owned in Jun 2026, down from $0.94 in Dec 2022.

PeriodJun 2026Dec 2025Dec 2024Dec 2023Dec 2022
Owes vs Owns 0.88× 0.90× 0.94× 0.94× 0.94×

Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.

Amgen Inc. Assets & Liabilities Breakdown (USD millions)

What it owns — Dec 2025

Cash & short-term investments 10.1%Receivables 10.6%Inventory 6.9%Fixed assets (tangible) 8.7%Intangible assets 45.2%Other assets 18.5%

How it's funded — Dec 2025

Short-term debt 5.1%Long-term debt 55.2%Payables 2.6%Other liabilities 27.6%Shareholders' equity 9.6%
Line Item Dec 2025Dec 2024Dec 2023Dec 2022
Assets
Cash & short-term investments9,129.011,973.010,944.09,305.0
Receivables9,570.06,782.07,942.06,392.0
Inventory6,225.06,998.09,518.04,930.0
Fixed assets (tangible)7,913.06,543.05,941.05,427.0
Intangible assets40,956.046,336.051,270.031,609.0
Long-term investments0.00.00.00.0
Other assets16,793.013,207.011,539.07,458.0
Liabilities & equity
Short-term debt4,599.03,550.01,443.01,591.0
Long-term debt50,005.056,549.063,170.037,354.0
Payables2,367.01,908.01,590.01,572.0
Other liabilities24,957.023,955.024,719.020,943.0
Shareholders' equity8,658.05,877.06,232.03,661.0
Net tangible assets-32,298.0-40,459.0-45,038.0-27,948.0

Amgen Inc. Cash Flow

Line Item Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Operating Activities 9,958,000,000.0 11,490,000,000.0 8,471,000,000.0 9,721,000,000.0 —
Investing Activities -1,943,000,000.0 -1,046,000,000.0 -26,204,000,000.0 -6,044,000,000.0 —
Financing Activities -10,859,000,000.0 -9,415,000,000.0 21,048,000,000.0 -4,037,000,000.0 —

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.